Literature DB >> 30260764

Chronic Viral Neuroinflammation: Speculation on Underlying Mechanisms.

Elizabeth C Delery1,2,3, Andrew G MacLean1,2,3,4,5.   

Abstract

Viral infection in the brain can be acute or chronic, with the responses often producing foci of increasingly cytotoxic inflammation. This can lead to effects beyond the central nervous system (CNS). To stimulate discussion, this commentary addresses four questions: What drives the development of human immunodeficiency virus (HIV)-associated neurocognitive disorders, does the phenotype of macrophages in the CNS spur development of HIV encephalitis (HIVE), does continual activation of astrocytes drive the development of HIV-associated neurocognitive disorders/subclinical disease, and neuroinflammation: friend or foe? A unifying theory that connects each question is the issue of continued activation of glial cells, even in the apparent absence of simian immunodeficiency virus/HIV in the CNS. As the CNS innate immune system is distinct from the rest of the body, it is likely there could be a number of activation profiles not observed elsewhere.

Entities:  

Keywords:  HIV; astrocyte; neuropathogenesis

Mesh:

Year:  2018        PMID: 30260764      PMCID: PMC6350055          DOI: 10.1089/vim.2018.0093

Source DB:  PubMed          Journal:  Viral Immunol        ISSN: 0882-8245            Impact factor:   2.257


  98 in total

1.  TLR2 hypersensitivity of astrocytes as functional consequence of previous inflammatory episodes.

Authors:  Anja Henn; Susanne Kirner; Marcel Leist
Journal:  J Immunol       Date:  2011-01-31       Impact factor: 5.422

2.  Chemokine expression in simian immunodeficiency virus-induced AIDS encephalitis.

Authors:  V G Sasseville; M M Smith; C R Mackay; D R Pauley; K G Mansfield; D J Ringler; A A Lackner
Journal:  Am J Pathol       Date:  1996-11       Impact factor: 4.307

3.  Expression of the mannose receptor CD206 in HIV and SIV encephalitis: a phenotypic switch of brain perivascular macrophages with virus infection.

Authors:  Gerard E Holder; Christopher M McGary; Edward M Johnson; Rubo Zheng; Vijay T John; Chie Sugimoto; Marcelo J Kuroda; Woong-Ki Kim
Journal:  J Neuroimmune Pharmacol       Date:  2014-08-22       Impact factor: 4.147

4.  Plastic restriction of HIV-1 replication in human macrophages derived from M1/M2 polarized monocytes.

Authors:  Francesca Graziano; Elisa Vicenzi; Guido Poli
Journal:  J Leukoc Biol       Date:  2016-06-30       Impact factor: 4.962

Review 5.  Transendothelial migration of monocytes: the underlying molecular mechanisms and consequences of HIV-1 infection.

Authors:  Clare L V Maslin; Katherine Kedzierska; Nicole L Webster; William A Muller; Suzanne M Crowe
Journal:  Curr HIV Res       Date:  2005-10       Impact factor: 1.581

Review 6.  Toll-like receptors in health and disease in the brain: mechanisms and therapeutic potential.

Authors:  Mark L Hanke; Tammy Kielian
Journal:  Clin Sci (Lond)       Date:  2011-11       Impact factor: 6.124

7.  Soluble CD163 made by monocyte/macrophages is a novel marker of HIV activity in early and chronic infection prior to and after anti-retroviral therapy.

Authors:  Tricia H Burdo; Margaret R Lentz; Patrick Autissier; Anitha Krishnan; Elkan Halpern; Scott Letendre; Eric S Rosenberg; Ronald J Ellis; Kenneth C Williams
Journal:  J Infect Dis       Date:  2011-07-01       Impact factor: 5.226

8.  Enhanced expression of proinflammatory cytokines in the central nervous system is associated with neuroinvasion by simian immunodeficiency virus and the development of encephalitis.

Authors:  Marlene S Orandle; Andrew G MacLean; Vito G Sasseville; Xavier Alvarez; Andrew A Lackner
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

Review 9.  Monocyte maturation, HIV susceptibility, and transmigration across the blood brain barrier are critical in HIV neuropathogenesis.

Authors:  Dionna W Williams; Eliseo A Eugenin; Tina M Calderon; Joan W Berman
Journal:  J Leukoc Biol       Date:  2012-01-06       Impact factor: 4.962

Review 10.  Astrocytes: biology and pathology.

Authors:  Michael V Sofroniew; Harry V Vinters
Journal:  Acta Neuropathol       Date:  2009-12-10       Impact factor: 17.088

View more
  2 in total

Review 1.  Involvement of organelles and inter-organellar signaling in the pathogenesis of HIV-1 associated neurocognitive disorder and Alzheimer's disease.

Authors:  Nabab Khan; Norman J Haughey; Avindra Nath; Jonathan D Geiger
Journal:  Brain Res       Date:  2019-08-16       Impact factor: 3.252

2.  Cannabinoid receptor type 2 agonist JWH-133 decreases cathepsin B secretion and neurotoxicity from HIV-infected macrophages.

Authors:  Lester J Rosario-Rodríguez; Yamil Gerena; Luis A García-Requena; Luz J Cartagena-Isern; Juan C Cuadrado-Ruiz; Gabriel Borges-Vélez; Loyda M Meléndez
Journal:  Sci Rep       Date:  2022-01-07       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.